SALT LAKE CITY--(BUSINESS WIRE)--The extent to which genetics contribute to the development of addiction to opioid pain medication is the subject of a new investigation, funded by the National Institutes of Health (NIH). CRI Lifetree, a leader in specialized early stage research with particular expertise in pain, human abuse liability, psychiatry, neurology and diabetes, is among the facilities awarded the NIH research grant.
